Fmoc protected amino acids were from Chem-Impex International (Wood Dale, IL). Chelex@100 resins were obtained from Bio-Rad (Hercules, CA). Ultrapure Water was produced using a Thermo Scientific Barnstead Nanopure® Ultrapure Water System. Phenomenex (Torrance, CA, USA) and GE (Piscataway, NJ, USA), respectively. A Waters 1525 binary pump chromatography system was used for purification of some synthesized compounds using two elution buffers (0.1 v% TFA in de-ionized water as elution buffer A and 0.1 v% TFA in acetonitrile as elution buffer B). The Waters 1525 binary pump chromatography system was assembled with a SEC Superose FPLC column and used for analysis of the 64 Cu labeled cetuximab conjugates using DPBS as the elution buffer. Metal decontamination was done as previously described. 
Synthesis of CB-TE1K1P chelator and its derivatives:
Scheme S1: Synthesis of CB-TE1K1P and two analogs for bioconjugation All reactions were conducted under N 2 , unless otherwise described.
Compound 2.
Compound 2 was synthesized using as previously described. 
Chelator activation and functionalization:
Synthesis of CB-TE1A1P-NHS ester: To the mixture of CB-TE1A1P (9.6 mg, 25 µmol), NHS (2.5 mg, 22 µmol) and HOBt (3.0 mg, 22 µmol) in 0.5 mL anhydrous DMF, EDCI (3.9 mg, 20 µmol) was added. After it was stirred 1 h at 0 °C, the solvent was removed under reduced pressure to yield the title compound as a colorless solid that was used without further purification for conjugation to cetuximab. 
Synthesis of DBCO-CB-

Conjugation of CB-TE1A1P and CB-TE1K1P to N 3 -cetuximab via SPAAC and radiolabelling with 64 Cu
3-azidopropionic acid succinimidyl ester was prepared from 3-bromopropanoic acid as previously described. 4 The 3-azidopropionic acid succinimidyl ester (4.5 mg, 20.0 µmol) was added to the mixture of the cetuximab solution (14.5 mL, 0.2 µmol) and Na 2 HPO 4 buffer (0.1 M, pH = 8.2, 5.4 mL), and then the resulting mixture was incubated overnight at 4 °C with gentle rotation. The resulting azide-cetuximab conjugate was purified by Corning Spin-X ® concentrator and a Zeba desalting column column to a concentration of 2.0 mg/mL as previously described.
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The above purified azide-cetuximab was mixed with 100-fold CB-TE1K1P-PEG 4 
Determination of chelator to antibody ratio:
A carrier-added copper solution (10 μM 
Serum stability measurement:
64 Cu-labeled cetuximab-chelator conjugate (~100 μCi) was mixed with 0.2 mL fetal bovine serum, and the resulting mixture was incubated at 37 °C for 1, 2 and 3 days. After incubation, the radiochemical purity of the 64 Cu labeled cetuximab-chelator conjugate was determined by radio-FPLC.
In vitro Binding Affinity
The HCT116 cell line was provided by Dr. Bert Vogelstein (Johns Hopkins University).
HCT116 cells were cultured in DMEM medium supplemented with 10% FBS and 0.1% gentamicin in a 37ºC humidified 95% air, 5% CO2 incubator. The affinity of 64 Culabeled cetuximab conjugates for EGFR was determined by a saturation binding assay based on previously published methods. 
Serum stability measurement:
64 Cu-labeled cFLFLF-chelator conjugate (~50 μCi) was mixed with 0.2 mL fetal bovine serum, and the resulting mixture was incubated at 37 °C for 1 and 2 d. After incubation, the radiochemical purity of the 64 Cu labeled cFLFLFchelator conjugate was determined by radio-TLC ( Figure S2b ).
Log P measurement:
64 Cu-labeled cFLFLF-chelator conjugate (~5 μCi) was added to a 1.5 mL tube containing 500 μL of water and 500 μL of octanol. The resulting mixture was shaken vigorously for 20 min at room temperature, and then centrifuged at 5000 rpm for 10 min. Triplicate aliquots (200 μL) of octanol and aqueous layers were carefully separated and radioactivity of samples was counted on a Cobra II gamma counter. Log P was measured as log (radioactivity in octanol / radioactivity in water).
Density Functional Theory (DFT) Calculations: All calculations were conducted using density functional theory (DFT) as implemented in the Gaussian03 suite of ab initio quantum chemistry programs. 7 Geometry optimizations and vibrational frequency calculations were performed by using the unrestricted B3LYP exchange and correlation Figure S2 : a) 64 Cu-labeling of two cFlFlF-chelate conjugates; b) serum stability of these two functionals and the double-ζ 6-31+G(d,p) basis set for all atoms. [8] [9] [10] [11] Normal self consistent field (SCF) and geometry convergence criteria were employed and the geometry of complex Cu-CB-TE1K1P and Cu-CB-TE1A1P was optimized in the gas phase without the use of symmetry constraints. The effect of stereochemistry was not investigated in the calculation and the program selected the stereoisomers of both Cu complexes randomly.
